GBS Inc. (NYSE:GBS – Get Free Report) fell 1.9% on Tuesday . The stock traded as low as $0.6406 and last traded at $0.6642. 104,771 shares traded hands during mid-day trading, a decline of 89% from the average session volume of 955,325 shares. The stock had previously closed at $0.6768.
GBS Price Performance
The stock has a market cap of $9.99 million, a price-to-earnings ratio of -1.20 and a beta of 1.32. The company’s fifty day moving average price is $1.00 and its 200-day moving average price is $1.41.
GBS Company Profile
GBS Inc operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.
See Also
- Five stocks we like better than GBS
- Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio
- Keysight Technologies’ Surge: The Market Wakes Up to This AI Play
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Is American Express the Credit Stock For a K-Shaped Economy?
- Expert Stock Trading Psychology Tips
- Powering Up: How a Credit Upgrade Fuels Vistra’s AI Ambitions
Receive News & Ratings for GBS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GBS and related companies with MarketBeat.com's FREE daily email newsletter.
